3 reports

EGP-## will be administered using the EyeGate II Ocular Drug Delivery System.

  • Autoimmune Disease
  • Therapy
  • United States
  • Product Initiative
  • Galapagos NV

EGP-## will be administered using the EyeGate II Ocular Drug Delivery System.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Anterior Uveitis - Product Development Milestones

EGP-## will be administered using the EyeGate II Ocular Drug Delivery System.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative